• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NOX 3.08% 6.7¢

NOXOPHARM LIMITED

Noxopharm Limited is an Australia-based biotechnology company. The Company is engaged in... Noxopharm Limited is an Australia-based biotechnology company. The Company is engaged in the discovery and development of treatments for cancer and inflammation. The Company has three active drug development programs: its clinical drug candidate Veyonda, plus two technology platforms, Chroma (oncology) and Sofra (inflammation and autoimmunity), which provide the basis for the active development of a growing pipeline of drugs. Veyonda (Idronoxil) is an adjuvant therapy in chemotherapy and radiotherapy in the treatment of late-stage cancers. The Chroma drug candidates have bioactive properties, which it is exploring primarily in the anti-cancer space. Its Sofra platform is centered around short nucleic acid sequences called oligonucleotides, which can act on specific cell receptors to stop inflammation, which is a source of various debilitating and lethal diseases. It is also conducting a dose escalation and dose expansion study of NOX66 in the treatment of COVID-19 infection.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NOX 13/03/24 22 6.7K
13/03/24 Last post  19661966 Comments Created with Sketch.  22  Views Created with Sketch.  6.7K 
NOX 21/02/24 3 1.5K
21/02/24 Last post  19661966 Comments Created with Sketch.  3  Views Created with Sketch.  1.5K 
NOX 07/02/24 2 1.2K
07/02/24 Last post  19661966 Comments Created with Sketch.  2  Views Created with Sketch.  1.2K 
NOX
the next Disallowed
19/01/24 11 6.3K
19/01/24 Last post  19661966 Comments Created with Sketch.  11  Views Created with Sketch.  6.3K 
NOX 18/12/23 0 377
18/12/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  377 
NOX 18/12/23 0 260
18/12/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  260 
NOX 28/11/23 45 18K
28/11/23 Last post  boundaryrider66 Comments Created with Sketch.  45  Views Created with Sketch.  18K 
NOX 16/11/23 2 1.1K
16/11/23 Last post  19661966 Comments Created with Sketch.  2  Views Created with Sketch.  1.1K 

See All Discussions arrow Created with Sketch.

Timeline

Appendix 4D and Half Year 2024 Financial Report
27 Feb 08:01
 
Noxopharm extends Hudson Institute strategic partnership
13 Feb 08:06
 
December 2023 Quarterly Activities Report and Appendix 4C
22 Jan 12:31
 
Change of Director's Interest Notice - GM
18 Dec 10:23
 
Notification of cessation of securities - NOX
18 Dec 08:18
 
Results of Meeting
16 Nov 16:10
 
View More arrow Created with Sketch.
(20min delay)
Last
6.7¢
Change
0.002(3.08%)
Mkt cap ! $19.58M
Open High Low Value Volume
6.5¢ 6.7¢ 6.5¢ $2.465K 37.67K

Buyers (Bids)

No. Vol. Price($)
2 32000 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.7¢ 88899 1
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
6.5¢
  Change
0.002 ( 2.36 %)
Open High Low Volume
6.5¢ 6.5¢ 6.2¢ 21992
Last updated 15.32pm 29/03/2024 ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.